![]() |
同义名 : | - |
CAS号 : | 162112-37-0 | |
货号 : | A1176671 | |
分子式 : | C18H17F3N4O2S | |
纯度 : | 99%+ | |
分子量 : | 410.41 | |
MDL号 : | MFCD00938572 | |
存储条件: |
Pure form Sealed in dry, 2-8°C In solvent -20°C:3-6个月-80°C:12个月 |
|
溶解度 : | - | |
动物实验配方: |
生物活性 | |||
---|---|---|---|
描述 | RWJ 50271 is a selective, orally active inhibitor of LFA-1/ICAM-1 interaction with an IC50 value of 5.0 μM (HL60 cells). RWJ 50271 inhibits LFA-1/ICAM-1-mediated cell adhesion. RWJ 50271 inhibits the binding of plastic immobilised SICAM to peripheral blood lymphocytes. RWJ 50271 inhibits peripheral blood lymphocyte adhesion to plastic immobilised SICAM-1. RWJ 50271 inhibits human and murine NK activity in an LFA-1/ICAM-1-dependent natural killer cytotoxicity assay (IC50=5.0 μM). RWJ 50271 does not inhibit Mac-1/ICAM-1, E-selectidsialyl Lewis X, or VLA-4/VCAM-1 mediated cell adhesion at 20 μM. It does not alter the expression level of LFA-1 in HL60 cells[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.44mL 0.49mL 0.24mL |
12.18mL 2.44mL 1.22mL |
24.37mL 4.87mL 2.44mL |